{"status": "Ok", "redirect_url": "https://www.businesswire.com/news/home/20260531664389/en/Bristol-Myers-Squibb-Announces-Opdivo%C2%AE-nivolumab-in-Combination-with-AVD-Receives-Expanded-EU-Label-with-Approval-in-Frontline-Advanced-Classical-Hodgkin-Lymphoma", "message": "News view counter 769564 successfully enlarged"}